share_log

Quest Diagnostics Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

DowjonesNews MarketWatch ·  Nov 23, 2021 16:50

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Quest Diagnostics Inc. (DGX) inched 0.20% higher to $151.04 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.17% to 4,690.70 and the Dow Jones Industrial Average rising 0.55% to 35,813.80. This was the stock's third consecutive day of gains. Quest Diagnostics Inc. closed $9.52 short of its 52-week high ($160.56), which the company achieved on September 9th.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Laboratory Corp. of America Holdings (LH) rose 0.76% to $285.91, Qiagen N.V. (QGEN) fell 0.42% to $54.85, and Sonic Healthcare Ltd. ADR rose 0.61% to $29.89. Trading volume (536,952) remained 774,009 below its 50-day average volume of 1.3 M.

Data source: Dow Jones Market Data, FactSet. Data compiled November 23, 2021.

-MarketWatch Automation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment